The U.S. Food and Drug Administration (FDA) has approved carbidopa-levodopa-entacapone (Stalevo^®) to treat Parkinson's disease in the following situations:

As a substitution for carbidopa-levodopa (Sinemet^®) plus entacapone (Comtan^®) in people already taking these medications

As a replacement for carbidopa-levodopa in people experiencing "wearing-off" symptoms who take 600 mg of levodopa per day or less and who are not experiencing dyskinesia (a movement disorder that is a side effect of carbidopa-levodopa).

Prior to prescribing carbidopa-levodopa-entacapone, your healthcare provider needs information on your complete medical history and any other drugs you are taking. This will help ensure a safe, effective treatment process.

(Click Carbidopa-Levodopa-Entacapone for more information, including how this medication works, side effects to be aware of, and general dosing guidelines.)

Carbidopa-Levodopa-Entacapone Info

Written by/reviewed by: Arthur Schoenstadt, MD

Last reviewed by: Arthur Schoenstadt, MD

Carbidopa-Levodopa-Entacapone

Side Effects of Carbidopa-Levodopa-Entacapone

What Is Carbidopa-Levodopa-Entacapone Used For?

Carbidopa-Levodopa-Entacapone Dosage

Drug Interactions With Carbidopa-Levodopa-Entacapone

Precautions and Warnings With Carbidopa-Levodopa-Entacapone

Referring Pages:

Articles

Advertise with Us

About eMedTV

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.